Clinical prediction of pathogenic variants in non-coding regions of the human genome.
Petrazzini, B. O.; Lopez-Bello, F.; Naya, H.; Spangenberg, l.
Show abstract
Whole genome sequencing has become a wide-spread diagnostic tool for rare diseases patients. This broadens analyses to non-coding regions of the genome showing strong evidence of clinical significance for human Mendelian diseases. Notwithstanding its importance, current in-silico prediction tools are restricted to coding sequences which limits its applicability. Additionally, lack of power in discriminating variants of uncertain significance (VUS) limits its clinical utility. Here we present PANCO, a genome-wide pathogenicity prediction tool aiming at reclassification of VUS with a rigorous imputation workflow adapted for non-coding variants. PANCO integrates functional, evolutionary and population frequency information to capture emerging biological signals correctly reclassifying VUS. Importantly, PANCO shows remarkable power in an external validation set, on VUS (AUROC=0.99 and AUROC=0.89, respectively).
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genome Alert!: a standardized procedure for genomic variant reinterpretation and automated genotype-phenotype reassessment in clinical routine 96%
- Reducing Sanger Confirmation Testing through False Positive Prediction Algorithms 95%
- The Importance of Automation in Genetic Diagnosis: Lessons from Analyzing an Inherited Retinal Degeneration Cohort with the Mendelian Analysis Toolkit (MATK) 95%
Similar papers in this journal
- MetaRNN: Differentiating Rare Pathogenic and Rare Benign Missense SNVs and InDels Using Deep Learning 97%
- Recommendations for clinical interpretation of variants found in non-coding regions of the genome 95%
- Genome-wide prediction of pathogenic gain- and loss-of-function variants from ensemble learning of diverse feature set 95%
Similar papers in this journal
- Evidence-based calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for clinical use of PP3/BP4 criteria 96%
- Advanced variant classification framework reduces the false positive rate of predicted loss of function (pLoF) variants in population sequencing data 95%
- Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel 95%
Similar papers in this journal
- ConsensuSV-ONT - a modern method for accurate structural variant calling 94%
- Can imputation in a European country be improved by local reference panels? The example of France 94%
- The application of Large Language Models to the phenotype-based prioritization of causative genes in rare disease patients 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.